Laboratory Investigation · 2019 · 35 citations · 31 references
MedicineOncologyPathologyBiomedical ImagingCellular PathologyNeoplasiaBiomarkers In PathologyCancer BiomarkersColorectal CancerImmunohistochemistryStaining TechniquesTumor CharacterizationColorectal Cancer BiomarkersDigital Image AnalysisDigital Pathology AnalysisMultiplex Fluorescence ImagingMultiplex StainingPrognostic BiomarkersProtein Expression BiomarkersTissue Microarray Analysis
Flourescence-based multiplex immunohistochemistry (mIHC) combined with multispectral imaging and digital image analysis (DIA) is a quantitative high-resolution method for determination of protein expression in tissue. We applied this method for five biomarkers (CDX2, SOX2, SOX9, E-cadherin, and β-catenin) using tissue microarrays of a Norwegian unselected series of primary colorectal cancer. The data were compared with previously obtained chromogenic IHC data of the same tissue cores, visually assessed by the Allred method. We found comparable results between the methods, although confirmed that DIA offered improved resolution to differentiate cases with high and low protein expression. However, we experienced inherent challenges with digital image analysis of membrane staining, which was better assessed visually. DIA and mIHC enabled quantitative analysis of biomarker coexpression on the same tissue section at the single-cell level, revealing a strong negative correlation between the differentiation markers CDX2 and SOX2. Both methods confirmed known prognostic associations for CDX2, but DIA improved data visualization and detection of clinicopathological and biological associations. In summary, mIHC combined with DIA is an efficient and reliable method to evaluate protein expression in tissue, here shown to recapitulate and improve detection of known clinicopathological and survival associations for the emerging biomarker CDX2, and is therefore a candidate approach to standardize CDX2 detection in pathology laboratories.
31
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Juha Kononen, Lukas Bubendorf, Anne Kallionimeni et al. · Nature Medicine · 1998 · 4.1K citations
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
D. Craig Allred, Jennet Harvey, Melora D. Berardo et al. · PubMed · 1998 · 2.2K citations
Medicine, Cancer Biology, Oncology +16
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade
Steve Lu, Julie E. Stein, David L. Rimm et al. · JAMA Oncology · 2019 · 622 citations · Full text
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
Piero Dalerba, Debashis Sahoo, Soonmyung Paik et al. · New England Journal of Medicine · 2016 · 481 citations · Full text
Medicine, Cancer Biology, Oncology +17